TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway.
Lei J, Zhu Q, Guo J, Chen J, Qi L, Cui M, Jiang Z, Fan C, Wang L, Lai T, Jin Y, Si L, Liu Y, Yang Q, Bao D, Guo R.
Lei J, et al.
J Transl Med. 2024 Dec 27;22(1):1151. doi: 10.1186/s12967-024-05833-0.
J Transl Med. 2024.
PMID: 39731053
Free PMC article.